Showing results (51-60 of 435) with videos related to

Sort By:
Pageof 44
European Journal of Heart Failure|August 11, 2025
A multicentre, randomized, double-blind, active and placebo-controlled study of pecavaptan, a dual V1a/V2 vasopressin receptor antagonist, in patients with acute heart failure: The AVANTI trialJames E Udelson, Steven R Goldsmith, Daniel Burkhoff, et al.
European Journal of Heart Failure|December 10, 2024
Machine learning approach to identify phenotypes in patients with ischaemic heart failure with reduced ejection fractionLuca Monzo, Emmanuel Bresso, Kenneth Dickstein, et al.
Indian Pacing and Electrophysiology Journal|April 9, 2015
What is The Utility of Electrophysiological Study in Elderly Patients with Syncope and Heart Disease?Rumas Aslam, Nicolas Girerd, Beatrice Brembilla-Perrot
Journal of the American Heart Association|March 13, 2026
Hyaluronan and Syndecan-1: Linking Glycocalyx Degradation to Development and Progression of Heart Failure With Preserved Ejection FractionEstela Rocha-Oliveira, Jeremy Lagrange, Mohammad Jahangiri, et al.
European Journal of Heart Failure|November 27, 2025
Pharmacological treatment for patients with obesity and heart failure: Focus on glucagon-like peptide-1 receptor agonists. European Journal of Heart Failure expert consensus documentLuca Monzo, Gianluigi Savarese, Wilfried Mullens, et al.
Pacing and Clinical Electrophysiology : PACE|May 14, 2018
Unresolved questions associated with the management of ventricular preexcitation syndromeBéatrice Brembilla-Perrot, Nicolas Girerd, Jean-Marc Sellal
Nature Cardiovascular Research|March 5, 2026
Strategies to improve regional representation in heart failure randomized controlled clinical trialsGuillaume Baudry, Luca Monzo, Rebecca A V Newton, et al.
ESC Heart Failure|April 11, 2020
Daily home monitoring of potassium, creatinine, and estimated plasma volume in heart failure post-dischargePatrick Rossignol, Renaud Fay, Nicolas Girerd, et al.
International Journal of Cardiology|August 29, 2021
Sodium-glucose co-transporter-2 inhibitors eligibility in patients with heart failure with reduced ejection fractionLuca Monzo, Ilaria Ferrari, Francesco Cicogna, et al.
Clinical Interventions in Aging|December 15, 2010
Clinical and economic aspects of the use of nebivolol in the treatment of elderly patients with heart failureDonatella Del Sindaco, Maria Denitza Tinti, Luca Monzo, et al.
Pageof 44